Autopsy report · NCT01718808

Cetuximab for Elderly Patients With mCRC

Cause of deathOther Automatic label, confidence 0.5, unverified. How labels are made.

“FU for 3 years from randomization as initially planned is stopped as we do not expect any changes to the endpoints in the future after one year of FU.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 4 years 2 months before it stopped.
24 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Swiss Cancer Institute
Sponsor type: University, hospital or other
Conditions: Metastatic Colorectal Cancer
Interventions: Cetuximab; Capecitabine
Participants: 24
Sites: 14
Countries: Switzerland

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.